Ernexa Therapeutics Inc. Deferred Rent Credit, Noncurrent
Ernexa Therapeutics Inc. (ERNA) had Deferred Rent Credit, Noncurrent of $231.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRentCreditNoncurrent · last filed 2018-03-09
- 2017-09-30: Deferred Rent Credit, Noncurrent $231.00K.
- 2017-06-30: Deferred Rent Credit, Noncurrent $281.00K.
- 2016-12-31: Deferred Rent Credit, Noncurrent $371.00K.
| Period end | Deferred Rent Credit, Noncurrent |
|---|---|
| 2017-09-30 | $231.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $281.00K 10-Q · filed 2017-08-04 |
| 2016-12-31 | $371.00K 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |